Table 2.
Clinical Characteristics in Patients with IgG4-RD Involving Coronary Artery.
| Reference | Age/Sex | Symptom | Coronary Stenosis | Coronary Aneurysm | IgG4 (mg/dL) | Treatment | Outcome | Other lesions |
|---|---|---|---|---|---|---|---|---|
| 6 | 63/F | Dyspnea | + | - | 456 | Bypass | - | AAA |
| 9 | 75/M | Chest pain | + | - | 2,510 | PSL 15 mg/day Bypass | - | AAA, Pancreatitis, Parotitis |
| 10 | 64/M | Dyspnea | - | + | - | PSL | - | Interstitial nephritis |
| 11 | 71/M | - | + | + | 2,720 | PSL, CV | - | AAA, Pancreatitis Sialadenitis, Cholangitis, |
| 12 | 66/M | Chest pain | + | - | 564 | Bypass | - | - |
| 13 | 75/M | - | + | - | 625 | PSL 20 mg/day | - | Aortitis |
| 14 | 72/M | Dyspnea | + | - | - | PSL 50 mg/day, Rituximab Bypass | - | Uveitis, Lung |
| 15 | 60/M | - | + | + | 1,350 | PSL 20 mg/day | - | Aortitis, Sialadenitis, Pancreatitis |
| 18 | 62/M | - | - | - | 2,170 | PSL 40 mg/day (0.6 mg/kg/day) | Improved | AAA |
| The present case | 59/M | - | - | - | 2,920 | PSL 40 mg/day (0.6 mg/kg/day) | Improved | AAA |
PSL: prednisolone, CY: Cyclophosphamide, Bypass: coronary artery bypass, AAA: abdominal aortic aneurysm